In October, Corteva’s board of directors unanimously approved a plan to separate the company’s crop protection business and its seed business into two independent companies.
Read More
The treatment uses a combination of two drugs to battle the cancer in addition to surgery to remove tumors.
Read More
Indianapolis-based agricultural giant Corteva, which plans to separate into two independent companies, said it hasn’t yet decided where the companies will be based.
Lilly’s latest commitment at the LEAP District brings the company’s total investment there since 2022 to $18 billion.
Lesley Weidenbener and Richard DiMarchi still works a full schedule, researching and teaching at Indiana University.
The serial entrepreneur also launched the affiliated Longevity Today, a website that identifies, processes and summarizes life sciences research and offers information to the public through AI personas.
The Indianapolis-based drugmaker reported profit of $7.4 billion for the first quarter, up from $2.8 billion in the same period a year earlier.
The Indianapolis-based drugmaker will partner with Profluent to develop and commercialize treatments for diseases with severe unmet needs.
The acquisition is the latest in a series of recent deals that Indianapolis-based Eli Lilly and Co. has made to increase its cancer-treatment pipeline.
The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal analysis and regulatory compliance.
The region stands out for its prowess in invention and innovation, but competing markets have mastered telling their stories, according to speakers at IBJ’s Life Sciences Power Breakfast.
Dr. Mark Payne, a professor of pediatrics at the Indiana University School of Medicine and a pediatric cardiologist at Riley Children’s Health, has been working on a treatment for a neurodegenerative condition called Friedreich’s ataxia for decades.
The focus of the agreement is to meet the evolving needs of Indiana’s orthopedic sector, which represents one-third of the industry’s global workforce.
Derek B. Groves will join Community Health Network Foundation in May as part of a planned leadership transition. He will succeed longtime CEO Joyce Irwin.
The company has a goal to build a massive bank of bone marrow from deceased organ donors to treat patients with blood cancers and improve organ transplantations.
Hospital CEO Brenda Reetz the insurance underpayment situation impacts patient bills, hospital stability and access to care. Indianapolis-based Anthem said it is working with the hospital to resolve the problem.
Through the collaboration, Telix and Regeneron expect to develop and commercialize next-generation radiopharmaceutical therapies targeting cancer.
Luke Kissam will lead New Corteva after Corteva officially separates its pesticide and seed businesses into two independent, publicly traded companies.
The Indianapolis-based drugmaker has started shipping the new pill to retail pharmacies.
The budget proposal calls for a new 840,000-square-foot tower that would replace the aging Richard L. Roudebush Veterans Administration Medical Center.
Witham’s announcement comes amid a series of recent moves by Parkview Health involving expansion into areas of the state away from its headquarters in Fort Wayne.
Facilities in Greenfield and Knox are at the heart of a lawsuit that seeks to replace the centers’ Indianapolis-based operator, Crossroads Health Management LLC, over allegations of financial mismanagement and revenue diversion.
